The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ophtha.2015.12.009PMID 26786511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• COMPARISON OF MANUAL AND SEMIAUTOMATED FUNDUS AUTOFLUORESCENCE ANALYSIS OF MACULAR ATROPHY IN STARGARDT DISEASE PHENOTYPE

  2016cited by this paper
• INSIGHTS INTO AUTOSOMAL DOMINANT STARGARDT-LIKE MACULAR DYSTROPHY THROUGH MULTIMODALITY DIAGNOSTIC IMAGING

  2016cited by this paper
• Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium.

  2015cited by this paper
• Predicting Progression of ABCA4-Associated Retinal Degenerations Based on Longitudinal Measurements of the Leading Disease Front.

  2015cited by this paper
• Assessment of estimated retinal atrophy progression in Stargardt macular dystrophy using spectral-domain optical coherence tomography

  2015cited by this paper
• Early-onset stargardt disease: phenotypic and genotypic characteristics.

  2015cited by this paper
• Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN•OCT consensus.

  2014cited by this paper
• Predictors of visual acuity and genotype-phenotype correlates in a cohort of patients with Stargardt disease

  2014cited by this paper
• Clinical and Molecular Characteristics of Childhood-Onset Stargardt Disease

  2014cited by this paper
• ISCEV Standard for full-field clinical electroretinography (2015 update)

  2014cited by this paper
• Macular function and morphologic features in juvenile stargardt disease: longitudinal study.

  2014cited by this paper
• A longitudinal study of stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations.

  2013cited by this paper
• A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.

  2013cited by this paper
• Relationship between foveal cone structure and clinical measures of visual function in patients with inherited retinal degenerations.

  2013cited by this paper
• COMPARISON OF COLOR FUNDUS PHOTOGRAPHS AND FUNDUS AUTOFLUORESCENCE IMAGES IN MEASURING GEOGRAPHIC ATROPHY AREA

  2012cited by this paper
• The bisretinoids of retinal pigment epithelium.

  2012cited by this paper
• Familial discordance in Stargardt disease

  2012cited by this paper
• Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.

  2012cited by this paper
• The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).

  2012cited by this paper
• Progression of retinal pigment epithelial atrophy in stargardt disease.

  2012cited by this paper
• Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials.

  2012cited by this paper
• Effects of smoking on ocular health

  2011cited by this paper
• Quantitative measurements of autofluorescence with the scanning laser ophthalmoscope.

  2011cited by this paper
• Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP).

  2011cited by this paper
• Analysis of autofluorescent retinal images and measurement of atrophic lesion growth in Stargardt disease.

  2010cited by this paper
• Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31.

  2010cited by this paper
• Structure-Function Correlation of the Human Central Retina

  2010cited by this paper
• Fundus autofluorescence imaging in age-related macular degeneration and geographic atrophy.

  2010cited by this paper
• Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.

  2010cited by this paper
• A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.

  2009cited by this paper
• ABCA4 disease progression and a proposed strategy for gene therapy.

  2009cited by this paper
• Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium.

  2008cited by this paper
• Visual acuity as an outcome measure in clinical trials of retinal diseases.

  2007cited by this paper
• The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials.

  2007cited by this paper
• Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations.

  2007cited by this paper
• Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD.

  2006cited by this paper
• Revision of visual impairment definitions in the International Statistical Classification of Diseases

  2006cited by this paper
• In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa.

  2005cited by this paper
• Automated analysis of digital fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration using confocal scanning laser ophthalmoscopy (cSLO)

  2005cited by this paper
• OUTCOME MEASURES AND THEIR APPLICATION IN CLINICAL TRIALS FOR RETINAL DEGENERATIVE DISEASES: Outline, Review, and Perspective

  2005cited by this paper
• Visual acuity loss and clinical observations in a large series of patients with Stargardt disease.

  2003cited by this paper
• Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.

  2001cited by this paper
• A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy

  1997cited by this paper
• Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus.

  1994cited by this paper
• Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.

  1991cited by this paper
• Visual acuity loss in patients with Stargardt's macular dystrophy.

  1987cited by this paper
• Retinal Pigment Epithelial Abnormalities in Fundus Flavimmaculatus

  1980cited by this paper
• Retinal pigment epithelial abnormalities in fundus flavimaculatus: a light and electron microscopic study.

  1980cited by this paper
• Über familiäre, progressive Degeneration in der Maculagegend des Auges

  1909cited by this paper

• Longitudinal Changes of Fundus Autofluorescence and Correlation With Visual Acuity in ABCA4-Associated Stargardt Disease.

  2026cites this paper
• Mental health outcomes in patients with inherited retinal diseases: a systematic review and meta-analysis.

  2026cites this paper
• Genetic Correlates of Phenotypic Variability in c.5882G>A p.(Gly1961Glu)-Associated Stargardt Disease

  2026cites this paper
• Automated Quantification of Decreased FAF in Stargardt Disease Using Starguage: Validation Against Manual Grading Standards

  2026cites this paper
• Baseline Relationships between Visual Function and Inflammatory Markers in the Registry of Moderated-Stage Retinitis Pigmentosa

  2025cites this paper
• Addressing Challenges in Developing Treatments for Inherited Retinal Diseases: Recommendations From the Third Monaciano Symposium

  2025cites this paper
• Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial

  2025cites this paper
• Advances in machine learning for ABCA4-related retinopathy: segmentation and phenotyping

  2025cites this paper
• ABCA4-associated disease in childhood and adolescence– a phenotype study

  2025cites this paper
• Longitudinal study in autosomal recessive PROM1 inherited retinal disease

  2025cites this paper
• Recent Advancements in the Treatment of Age‐Related Macular Degeneration

  2025cites this paper
• Juvenile macular degeneration in nonhuman primates generated by germline knockout of ABCA4 gene.

  2025cites this paper
• Multimodal imaging in autosomal recessive Stargardt’s disease

  2025cites this paper
• Progression of Atrophy as a Function of ABCA4 Variants and Age of Onset in Stargardt Disease

  2025cites this paper
• PCARE-Associated Retinopathy – Genetics, Clinical Characteristics, and Natural History

  2025influential citation
• Study protocol for a prospective natural history registry investigating the relationships between inflammatory markers and disease progression in retinitis pigmentosa: the RP-PRIMARY study

  2025cites this paper
• 12-year cumulative incidence rate of rare retinal diseases: a nationwide study in Korea

  2025cites this paper
• Looking outside the box with a pathology aware AI approach for analyzing OCT retinal images in Stargardt disease

  2025cites this paper
• Bisretinoids as a Source of Early Photoreceptor Pathology in Stargardt Disease

  2025cites this paper
• Dysregulated DNA Methylation in Abca4-/- Retinal Pigment Epithelium: Insights into Early Stage of Stargardt Disease

  2025cites this paper
• Characterising microstructural retinal changes in children with inherited retinal dystrophies – a retrospective observational cross-sectional study

  2025cites this paper
• Rescue of Aberrant Splicing Caused by a Novel Complex Deep-intronic ABCA4 Allele

  2024cites this paper
• Pentosan Polysulfate Maculopathy: Final Outcomes from a 4-Year Prospective Study of Disease Progression after Drug Cessation.

  2024cites this paper
• Strabismus in an Adolescent With Stargardt Disease: An Atypical Presentation

  2024cites this paper
• Recurrent and Concurrent Prediction of Longitudinal Progression of Stargardt Atrophy and Geographic Atrophy towards Comparative Performance on Optical Coherence Tomography as on Fundus Autofluorescence

  2024cites this paper
• Progression rate of macular retinal pigment epithelium atrophy in geographic atrophy and selected inherited retinal dystrophies. A systematic review and meta-analysis.

  2024cites this paper
• Presentation and Clinical Features of Stargardt Disease in a Series of Nigerian Patients

  2024cites this paper
• Censoring the Floor Effect in Long-Term Stargardt Disease Microperimetry Data Produces a Faster Rate of Decline

  2024cites this paper
• Effectiveness of Mp-3 Microperimetric Biofeedback Fixation Training For Low Vision Rehabilitation in Patients Treated With Corticosteroid Ivt in Retinal Vein Occlusions

  2024cites this paper
• Retinoic acid related orphan receptor α is a genetic modifier that rescues retinal degeneration in a mouse model of Stargardt disease and Dry AMD

  2024cites this paper
• GENOTYPE-PHENOTYPE SEVERITY CORRELATION IN A MULTICENTRIC PORTUGUESE COHORT OF ABCA4-ASSOCIATED RETINOPATHY

  2024cites this paper
• Optical Coherence Tomography in Inherited Macular Dystrophies: A Review

  2024cites this paper
• Automated identification of fleck lesions in Stargardt disease using deep learning enhances lesion detection sensitivity and enables morphometric analysis of flecks

  2024cites this paper
• ABCA4 variant screening in a Turkish cohort with Stargardt disease

  2024cites this paper
• Recurrent and Concurrent Prediction of Longitudinal Progression of Stargardt Atrophy and Geographic Atrophy

  2024cites this paper
• Optical Coherence Tomography and Optical Coherence Tomography Angiography in Pediatric Retinal Diseases

  2023cites this paper
• Endpoints for clinical trials in ophthalmology.

  2023cites this paper
• Updates on Emerging Interventions for Autosomal Recessive ABCA4-Associated Stargardt Disease

  2023cites this paper
• The progression of Stargardt Disease as determined by fundus autofluorescence over a 24-month period (ProgStar Report No. 17).

  2023cites this paper
• Clinical profile and demographic distribution of Stargardt disease phenotypes: An Electronic medical record-driven big data analytics from a multitier eye care network

  2023cites this paper
• The Progression of PROM1-associated retinal degeneration as determined by spectral-domain optical coherence tomography over a 24-months period.

  2023cites this paper
• Stem Cell Therapy in Stargardt Disease: A Systematic Review

  2023cites this paper
• Association Between Genotype and Phenotype Severity in ABCA4-Associated Retinopathy.

  2023cites this paper
• Using Ensemble OCT-Derived Features beyond Intensity Features for Enhanced Stargardt Atrophy Prediction with Deep Learning

  2023cites this paper
• Natural History of Stargardt Disease: The Longest Follow-Up Cohort Study

  2023cites this paper
• Local progression kinetics of macular atrophy in recessive Stargardt disease

  2023cites this paper
• Late-Onset Stargardt disease; a clinical condition may be misdiagnosed: a case report

  2023cites this paper
• Multimodal Phenomap of Stargardt Disease Integrating Structural, Psychophysical, and Electrophysiologic Measures of Retinal Degeneration

  2023cites this paper
• Deep phenotyping of PROM1-associated retinal degeneration

  2023cites this paper
• Stargardt macular dystrophy and therapeutic approaches

  2023cites this paper
• The current state of genetic testing platforms for inherited retinal diseases.

  2022cites this paper
• Stargardt Macular Dystrophy

  2022cites this paper
• Modeling inherited retinal dystrophies using induced pluripotent stem cells

  2022cites this paper
• Investigation of Structural Alterations in Inherited Retinal Diseases: A Quantitative SD-OCT-Analysis of Retinal Layer Thicknesses in Light of Underlying Genetic Mutations

  2022cites this paper
• Automated segmentation and feature discovery of age-related macular degeneration and Stargardt disease via self-attended neural networks

  2022cites this paper
• Anisometropia and asymmetric ABCA4-related cone-rod dystrophy

  2022cites this paper
• Vitamin A, systemic T-cells, and the eye: Focus on degenerative retinal disease

  2022cites this paper
• Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration

  2022cites this paper
• Automated Segmentation of Autofluorescence Lesions in Stargardt Disease.

  2022cites this paper
• Artificial intelligence for assessment of Stargardt macular atrophy

  2022cites this paper
• Kinetics of Heterogeneous Background in Stargardt’s Disease over Time

  2022influential citation
• The role of multimodal imaging and vision function testing in ABCA4-related retinopathies and their relevance to future therapeutic interventions

  2021cites this paper
• NEGATIVE VESSEL REMODELING IN STARGARDT DISEASE QUANTIFIED WITH VOLUME-RENDERED OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY

  2021cites this paper
• Imaging in inherited retinal disorders

  2021cites this paper
• Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease

  2021cites this paper
• An optometrist’s guide to the top candidate inherited retinal diseases for gene therapy

  2021cites this paper
• KCNV2-Associated Retinopathy: Detailed Retinal Phenotype and Structural Endpoints—KCNV2 Study Group Report 2

  2021cites this paper
• Artificial Intelligence (AI) Applications for Age-Related Macular Degeneration (AMD) and Other Retinal Dystrophies

  2021cites this paper
• Evaluation of photoreceptor function in inherited retinal diseases using rod‐ and cone‐enhanced flicker stimuli

  2021cites this paper
• Progression of Atrophy and Visual Outcomes in Extensive Macular Atrophy with Pseudodrusen-like Appearance

  2021cites this paper
• Automatic Segmentation in Multiple OCT Layers For Stargardt Disease Characterization Via Deep Learning

  2021cites this paper
• The Progression of Stargardt Disease using Volumetric Hill of Vision Analyses Over 24 Months: ProgStar Report No.15.

  2021cites this paper
• Pluripotent stem cell therapy for retinal diseases

  2021cites this paper
• Microvascular and metabolic alterations in retinitis pigmentosa and Stargardt disease

  2021cites this paper
• Structural evaluation in inherited retinal diseases

  2021cites this paper
• Stargardt disease: Multimodal imaging: A review

  2021cites this paper
• Measures of Function and Structure to Determine Phenotypic Features, Natural History, and Treatment Outcomes in Inherited Retinal Diseases.

  2021cites this paper
• Longitudinal Changes of Fixation Stability and Location within 24 Months in Stargardt Disease: ProgStar Report No. 16: Short title: Longitudinal Changes of Fixation in Stargardt Disease.

  2021cites this paper
• Characteristics and Clinical Course of Korean Patients Diagnosed with Stargardt Disease

  2021cites this paper
• An Overview of the Genetics of ABCA4 Retinopathies, an Evolving Story

  2021cites this paper
• Choosing Outcome Measures and Assessing Efficacy of Therapeutic Interventions in Inherited Retinal Diseases: The Importance of Natural History Studies

  2021cites this paper
• Longitudinal Changes in Scotopic and Mesopic Macular Function as Assessed with Microperimetry in Patients with Stargardt Disease: SMART Study Report No. 2: Short Title: Scotopic and Mesopic Macular Functions in Stargardt Disease.

  2021cites this paper
• Functional evaluation in inherited retinal disease

  2021cites this paper
• Microperimetry in Children’s Practice

  2021cites this paper
• Visual Acuity and Age of Symptom Onset in a Large Chinese Cohort of Patients with Stargardt Disease

  2021cites this paper
• PRINCIPLES OF ADAPTIVE OPTICS IN OPHTHALMOLOGY

  2020cites this paper
• Neural (Sensory) Retina

  2020cites this paper
• Reviewing the Role of Ultra-Widefield Imaging in Inherited Retinal Dystrophies

  2020cites this paper
• Findings from a Genotyping Study of over 1000 People with Inherited Retinal Disorders in Ireland

  2020cites this paper
• HOMOZYGOSITY FOR A NOVEL DOUBLE MUTANT ALLELE (G1961E/L857P) UNDERLIES CHILDHOOD-ONSET ABCA4-RELATED RETINOPATHY IN THE UNITED ARAB EMIRATES.

  2020cites this paper
• Faster Sensitivity Loss around Dense Scotomas than for Overall Macular Sensitivity in Stargardt Disease: ProgStar Report No. 14.

  2020cites this paper
• Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations

  2020influential citation
• Abnormal Visual Function Outside the Area of Atrophy Defined by Short-Wavelength Fundus Autofluorescence in Stargardt Disease

  2020cites this paper
• The Effect of Attention on Fixation Stability during Dynamic Fixation Testing in Stargardt Disease.

  2020cites this paper
• Biofeedback Rehabilitation and Visual Cortex Response in Stargardt's Disease: A Randomized Controlled Trial

  2020cites this paper
• Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months: ProgStar Report No. 13.

  2020cites this paper
• Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients

  2020cites this paper
• Prediction of Function in ABCA4-Related Retinopathy Using Ensemble Machine Learning

  2020cites this paper
• Factors Influencing Retinal Pigment Epithelium-Atrophy Progression Rate in Stargardt Disease

  2020cites this paper
• Clinical and genetic characteristics of 10 Japanese patients with PROM1‐associated retinal disorder: A report of the phenotype spectrum and a literature review in the Japanese population

  2020cites this paper